bispecific T-cell engager (Zymeworks)

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug Namebispecific T-cell engager (Zymeworks)

Drug Alias NameT-cell engaging bi-specific antibody (Zymeworks)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionImmunostimulantsT lymphocytes stimulants

TargetsUpdating

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesZymeworks Inc

China Registration ClassN/A

Develop Information

Active CompaniesZymeworks Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A